PREVNAR 20

US FDA approves Merck's pneumococcal vaccine for adults

Merck's vaccine, branded Capvaxive, helped produce an immune response against all 21 serotypes, or variations of the bacteria, that the shot targeted in a variety of adult populations across studies.